Pharma's Almanac | Platform Technology

30 Articles Available

1 2

Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

PAO-03-23-CL-06

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

PR-M03-23-03

T Cell Expansion Platform

Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose

PR-M02-23-03

CAR-T

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

PAO-12-022-CL-04

Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

PAO-12-022-NI-01

CAR-T and iPSC Platform Technologies

Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting

PR-M11-22-06

mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

PAO-10-022-CL-03

Yeast

Phenotypeca Pioneers the Use of Improved Baker's Yeast to Make Life-Saving Medicines Affordable and Accessible to Everyone

PR-M10-22-03

Series A Funding

Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma

PR-M10-22-02

Data Management System

Generis Celebrates New Milestones as Swathes of the Global Pharma Industry Default to CARA Life Sciences™ to Manage Critical Data and Content

PR-M06-22-06

Cell Line Development

Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow

PR-M06-22-04

Immuno-Oncology

Building Multiple Platforms to Address Difficult-to-Treat Cancers

PAO-05-22-R250-09

Enabling Drug Discovery Targeting Ion Channels

Ion Channels

Biomanufacturing

A Next-Generation Baker’s Yeast Biofoundry Presents Transformative Potential for Biomanufacturing

PAO-04-022-CL-10

Seed Funding

Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital

PR-M04-22-13

License Agreement

Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China

PR-M03-22-08

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

PR-M03-22-05

Antibody Therapeutics

Developing New Antibody Therapeutics for COVID-19 and Beyond

PAO-01-22-CL-01

Rare Diseases

Leveraging AI and RNA to Fight Rare Diseases

PAO-02-22-R250-17

Cancer Diagnostics

Envisioning a New Cancer Diagnostic and Therapeutic Platform

PAO-02-22-R250-11

Leadership Appointment

Generis Appoints Head of Life Sciences as CARA™ Growth Soars

PR-M01-22-20

Research Collaboration

BigHat Biosciences Completes First Stage of Research Collaboration With Amgen

PR-M01-22-08

Gene Editing

Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent

PAO-07-21-CL-06

Cell and Gene Therapy

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

PAO-05-21-CL-05

1 2

Platform Technology